A newly published Japanese study confirms UK Professor Angus
Dalgleish’s concerns about mRNA injections causing cancer. After the
findings of the study were published, Australian Professor Ian Brighthope has classified the injections as class one carcinogens.
More than a year ago, Professor Dr.
Angus Dalgleish, a renowned oncologist practising in the UK, first
published his concerns that his patients with melanoma were relapsing
after several years of being in remission.
“I could find none of the usual causes
but on further investigation, I realised that they had all had a
booster covid vaccine between three weeks and three months before their
cancer’s resurgence, the time in which their immune repression fails,”
he wrote in The Conservative Woman on Monday.
After raising the alarm that the
vaccine boosters could induce cancer relapse, he became aware of
literally dozens of people who had not had cancer before developing
leukaemia and lymphomas after the boosters.
In November 2022, Prof. Dalgleish wrote an open letter to the editor-in-chief of the medical journal The BMJ,
urging the journal that harmful effects of Covid injections be “aired
and debated immediately” because cancers and other diseases are rapidly
progressing among “boosted” people.
A few weeks later,
he reported that other oncologists had contacted him to say they were
seeing the same phenomenon of the recurrence of cancer in many melanoma
patients who had been stable for long periods.
“Since pointing this out publicly I
have been contacted by many physicians and patients from all over the
globe saying that they are not only seeing the same phenomenon but also
an increase in other cancers especially colorectal, pancreatic, renal
and ovarian,” he wrote at the beginning of this week.
Many people had covid vaccines against
their will, Prof. Dalgleish said. “Others gave in to the bullying of
the NHS and GPs who hounded them with texts and calls (which I myself
received regularly) about the importance of having a booster even though
they presented no evidence that it could be beneficial.”
Adding, “Having worked in vaccine
development for a decade I remembered an adage that if a vaccine needs a
booster, it doesn’t work!”
In his latest article, Prof. Dalgleish
highlighted several sources of evidence that have proved his concerns
to be justified. One source being a paper from Japan published last
week.
“It was available on a pre-publication server last year but now it has been peer-reviewed and published in Cureus. Titled ‘Increased age adjusted cancer mortality after the third mRNA lipid nanoparticle vaccine dose during the covid pandemic in Japan’,” he said.
The results are astounding. It shows
there was a deficit for all cancers in the year 2020 when the first and
second covid waves occurred. In 2021 there was an excess of deaths of
2.2 per cent and a 1.1 per cent increase in cancers. However, by 2022
the excess deaths had increased 9.6 per cent and cancer by 2.1 per
cent. This paper was completed and published before the 2023
figures release which will almost certainly be much worse. What is
remarkable here is that we are talking mortality, that is deaths from
cancer not incidence of it.
So what is the cause of this sudden increase? It is revealed in the title of the paper!
Massive cancer deaths study vindicates my warnings over covid boosters, The Conservative Woman, 15 April 2024
In an article published on Wednesday, retired Australian medical practitioner Professor Ian Brighthope highlighted the same Japanese paper and said:
Today, on behalf of my professional
friends and medical colleagues, I declare the mRNA vaccines to be class
one carcinogens. mRNA is also a broad-spectrum mutagen. mRNA must be
banned internationally.
mRNA is a class one carcinogen, Ian Brighthope, 17 April 2024
He then went on to explain what
carcinogens are, the process of carcinogenicity and how carcinogens are
classified before inviting readers to make up their own minds about how
carcinogenic mRNA injections are based on the findings of the Japanese
study.
Below are some extracts from Prof. Brighthope’s article but we encourage readers to read his informative article in full.
Carcinogens and Carcinogenicity
Carcinogens are substances, organisms
or agents capable of causing cancer by altering the cellular, genetic
and epigenetic mechanisms within the body, leading to the transformation
of normal cells into cancer cells. These agents can be chemical
substances, viruses or even certain types of radiation therapies used to
treat cancer.
Carcinogens do not necessarily cause
cancer in every case or under all circumstances. Factors such as the
amount and duration of exposure, the individual’s genetic makeup and
exposure to other environmental factors play a significant role in
determining whether a person exposed to a carcinogen will ultimately
develop cancer. Moreover, not all mutations caused by carcinogens lead
to cancer; only certain mutations in specific genes that regulate cell
growth, apoptosis, and DNA repair may result in uncontrolled cell
proliferation and cancer.
The process of carcinogenicity, also
known as carcinogenesis or tumour genesis, involves multiple stages
where normal cells undergo a series of changes at the cellular, genetic,
and epigenetic levels, resulting in abnormal cell division and the
formation of cancer.
Classification of Carcinogens
Carcinogens can be classified based on
their mode of action into genotoxic and non-genotoxic carcinogens.
Genotoxic carcinogens directly interact with DNA and/or the cellular
apparatus, affecting the integrity of the genome. Non-genotoxic
carcinogens exert their effects through mechanisms that do not involve
direct DNA damage.
International Agency for Research on Cancer (“IARC”) Classification
The IARC Monographs identify
factors that can increase the risk of human cancer, including lifestyle
factors. Interdisciplinary working groups of expert scientists review
the published studies and evaluate the weight of the evidence that an
agent can increase the risk of cancer. Agents are then categorised as
carcinogenic, probably or possibly carcinogenic, or not carcinogenic to
humans, based on the strength of the evidence.
The IARC Working Group also considers
the body of evidence as a whole, to reach an overall evaluation of the
carcinogenicity of the agent to humans. The categorisation of an agent
into one of four groups is a matter of scientific judgment that reflects
the strength of the evidence derived from studies in humans and in
experimental animals and from mechanistic and other relevant data.
The four IARC groups are:
- • Group 1: Sufficient evidence of carcinogenicity, the highest IARC
classification for carcinogenicity. [Agents that are judged to fall into
this category are also referred to as “class one carcinogens.”] - • Group 2A (probably carcinogenic to humans) or Group 2B (possibly
carcinogenic to humans): Limited evidence of carcinogenicity, a positive
association. - Group 3: Inadequate evidence of carcinogenicity.
- Group 4: Evidence suggesting lack of carcinogenicity.
World Cancer Research Fund (“WCRF”) and American Institute for Cancer Research (“AICR”) Classification
The 2007 WCRF and AICR Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective report
and subsequent tumour-specific updates are based on systematic reviews
of the scientific literature for food, nutrition and physical activity.
A WCRF and AICR Panel judged and
graded the evidence into five categories: convincing, probable, limited
(suggestive evidence), limited (no conclusion) or unlikely to affect
cancer risk.
Decide for yourselves the level of carcinogenicity that characterises mRNA
After describing how carcinogens are
classified, Prof. Brighthope invited readers to judge for themselves how
mRNA injections should be classified by sharing the conclusion from the
recently published Japanese study:
Statistically significant increases in
age-adjusted mortality rates of all cancer and some specific types of
cancer, namely, ovarian cancer, leukaemia, prostate,
lip/oral/pharyngeal, pancreatic, and breast cancers, were observed in
2022 after two-thirds of the Japanese population had received the third
or later dose of SARS-CoV-2 mRNA-LNP vaccine. These particularly marked
increases in mortality rates of these ERα-sensitive [Estrogen Receptors Alpha-sensitive]
cancers may be attributable to several mechanisms of the mRNA-LNP
vaccination rather than covid-19 infection itself or reduced cancer care
due to the lockdown.
Increased
Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle
Vaccine Dose During the COVID-19 Pandemic in Japan, Cureaus, 8 April 2024
As the title of his article stated, Prof. Brighthope classifies mRNA injections as a “class one carcinogen.”
Sources for this article include: mRNA is a class one carcinogen & a broad-spectrum mutagen, The Liberty Beacon, 18 April 2024
Source: Expose News
Click this link for the original source of this article.
Author: Planet Today
This content is courtesy of, and owned and copyrighted by, https://www.planet-today.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.